Fondazione Carlo Grandori

Utilizzare tecniche all’avanguardia per accelerare la scoperta di nuove terapie non tossiche e personalizzate per la cura del cancro ed altre malattie.

Photograph of Carla and Carlo GrandoriCarlo Grandori blueprint

Scientific and Advisory Board

Sandra Pellegrini, PhD

Director, Cytokine Signaling Unit, Dept. of Immunology, Pasteur Institute

Sandra PellegriniSandra Pellegrini received her Laurea degree in Biological Sciences at the Sapienza University of Rome. In 1986 she obtained her PhD in Basic Medical Sciences at NYU Medical School, New York. After 3 years as EMBO fellow at the Imperial Cancer Research Fund Laboratories in London, she moved to the Pasteur Institute in Paris. Since 2000, she heads the Cytokine Signaling Unit in the Department of Immunology of the Pasteur Institute. She is an Inserm Director of Research.

S. Pellegrini has played a leading role in unraveling signaling mechanisms of the key cytokines in host defense to pathogens. She successfully used somatic cell genetics to isolate cellular mutants and established the role of Jak protein tyrosine kinases in cytokine signaling. Her lab has a long track history in studies of the regulation and the function of Type I interferons involved in innate and adaptive immune responses. Sandra Pellegrini is author of 62 original articles in peer-reviewed journals.

Enzo Bonmassar MD, PhD

Full Professor of Pharmacology University of Rome "Tor Vergata", Department of Neuroscience.

Graduated in Pharmaceutical Chemistry, University of Padua.

M.D. cum laude, University of Pavia.

Enzo BonmassarProfessor Enzo Bonmassar is author or co-author of 241 Full Papers in the area of Oncology, Immunology, Molecular Biology and Cancer Chemotherapy. His main area of interest concerns drug-induced antigenic changes of malignant cells (i.e. “Chemical Xenogenization” phenomenon).

Rita Grandori, PhD

Associate Professor, Dept. of Biochemistry, University of Milan-Bicocca

Rita GrandoriRita Grandori, born in Milan in 1961, is associate professor of Biochemistry at the University Milano-Bicocca. At the University of Milan she completed her Masters degree in Biology in 1984, followed by her PhD in Molecular Biology in 1989 and her specialization in Biotechnology in 1991. She has been a visiting researcher at the European Laboratory of Molecular Biology (EMBL) in Heidelberg (Germany), at Princeton University in New Jersey (USA), and at the Universities of Salzburg and Linz (Austria), where she secured her professional qualification in Protein Science in 2002. Her research activity has focused on cell-cycle control, protein biochemistry, bioinformatics, and protein mass spectrometry. Her current projects focus on intrinsically disordered proteins and amyloid protein aggregation.

Ferdinando Grandori, PhD

Professor of Bioengineering and Director of the Institute of Biomedical Engineering at the Milan Polytechnic

Ferdinando GrandoriFerdinando Grandori is Director of the CNR Istituto di ingegneria Biomedica (Italian National Research Council - Institute of Biomedical Engineering). He holds faculty appointments at the Polytechnic of Milan (Bio-engineering of Neurosensory Systems). He has worked for over than three decades on modeling physiological functions, innovative methods and technologies for the analysis of biological signals, mainly related with auditory functions, and their applications to improve health and quality of life. More specifically his research interests were electrical and magnetic fields produced by motor and sensory organs; magnetic stimulation of central and peripheral neural structures; effects of electromagnetic fields at GSM and UMTS frequencies; biomedical informatics; response analysis, interpretation and scoring of otoacoustic emissions; protocols and standards for newborn hearing screening, early hearing diagnosis and intervention.

He promoted and organized the European Consensus Development Conference on Neonatal Hearing Screening (May 1998) and the NHS conferences. Since 1994 Dr. Grandori served as project leader of a number of multi-year international projects financed by the European Commission in Brussels (Biomed 1, Biomedicine and Health Program, Quality of Life) on technologies, models and protocols for hearing screening. Ferdi Grandori is the author of more than 100 articles on peer reviewed journals, editor of books and proceedings, and Guest Editor of about one dozen of special issues of international journals. Ferdi Grandori gave more than 250 communications at conferences and society meetings and has been invited to give lectures at more than 80 meetings in over than 24 countries. He is currently serving as Coordinator of Project AHEAD III (Assessment of Hearing in the Elderly: Aging and Degeneration - Integration through Immediate Intervention) financed by the European Commission (2009-2011) in the Area Health.